Chemopreventive potential of synergy1 and soybean in reducing azoxymethane-induced aberrant crypt foci in fisher 344 male rats

Journal of Nutrition and Metabolism

Volumn 2011, Issue , 2011, Pages

  Gourineni, V P ^a   Verghese, M ^a   Boateng, J ^a   Shackelford, L ^a   Bhat, K N ^a  

^a ALABAMA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE MAX; RATTUS;

EID: 84859889474     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2011/983038     Document Type: Article

References (62)

1. American Cancer Society, Facts, Figures and Statistics 2008 Atlanta, Ga, USA ACS
2. Painter N. S., Burkitt D. P., Diverticular disease of the colon: a deficiency disease of Western civilization. The British Medical Journal 1971 2 759 450 454 2-s2.0-0015236242
3. Goldin B. R., Gorbach S. L., The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. Journal of the National Cancer Institute 1976 57 2 371 375 2-s2.0-0017192270
4. Gorbach S. L., The intestinal microflora and its colon cancer connection. Infection 1982 10 6 379 384 2-s2.0-0020465919 (Pubitemid 13217016)
5. McGarr S. E., Ridlon J. M., Hylemon P. B., Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. Journal of Clinical Gastroenterology 2005 39 2 98 109 2-s2.0-12344253203 (Pubitemid 40130020)
6. Boursi B., Arber N., Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Current Pharmaceutical Design 2007 13 22 2274 2282 2-s2.0-34548266731 10.2174/138161207781368783 (Pubitemid 47317035)
7. Reddy B. S., Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents. Advances in Experimental Medicine and Biology 1997 400 931 936 2-s2.0-0031427793
8. Tsao A. S., Kim E. S., Hong W. K., Chemoprevention of cancer. Ca-A Cancer Journal for Clinicians 2004 54 3 150 180 2-s2.0-2942655078 (Pubitemid 38812180)
9. Umar A., Viner J. L., Richmond E., Anderson W. F., Hawk E. T., Chemoprevention of colorectal carcinogenesis. International Journal of Clinical Oncology 2002 7 1 2 26 2-s2.0-0036220296 (Pubitemid 34289909)
10. Burkitt D. P., Epidemiology of large bowel disease: the role of fibre. Proceedings of the Nutrition Society 1973 32 3 145 149 2-s2.0-0015698588
11. Pool-Zobel B., Van Loo J., Rowland I., Roberfroid M. B., Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. British Journal of Nutrition 2002 87 2 S273 S281 2-s2.0-0036288062 (Pubitemid 34692568)
12. Verghese M., Rao D. R., Chawan C. B., Williams L. L., Shackelford L., Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. Journal of Nutrition 2002 132 9 2809 2813 2-s2.0-0036715257 (Pubitemid 35013275)
13. Verghese M., Walker L. T., Shackelford L., Chawan C. B., Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats. Nutrition Research 2005 25 9 859 868 2-s2.0-26844448331 10.1016/j.nutres.2005.09.007 (Pubitemid 41446229)
14. Pool-Zobel B. L., Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. British Journal of Nutrition 2005 93 S73 S90 2-s2.0-23044449175 10.1079/BJN20041349 (Pubitemid 43073411)
15. Atkinson C., Frankenfeld C. L., Lampe J. W., Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Experimental Biology and Medicine 2005 230 3 155 170 2-s2.0-14344267019 (Pubitemid 40293689)
16. Omoni A. O., Aluko R. E., Soybean foods and their benefits: potential mechanisms of action. Nutrition Reviews 2005 63 8 272 283 2-s2.0-23844554843 10.1301/nr.2005.aug.272-283 (Pubitemid 41176916)
17. Heinonen S. M., Hoikkala A., Wähälä K., Adlercreutz H., Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. Journal of Steroid Biochemistry and Molecular Biology 2003 87 4-5 285 299 2-s2.0-0347992819 10.1016/j.jsbmb.2003.09.003 (Pubitemid 38036964)
18. Setchell K. D. R., Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 1998 68 6 1333S 1346S 2-s2.0-0031741906 (Pubitemid 28550909)
19. Setchell K. D. R., Cassidy A., Dietary isoflavones: biological effects and relevance to human health. Journal of Nutrition 1999 129 3 758S 767S 2-s2.0-0033011895
20. Wong J. M. W., Jenkins D. J. A., Carbohydrate digestibility and metabolic effects. Journal of Nutrition 2007 137 11 2539S 2546S 2-s2.0-35848954727 (Pubitemid 350058732)
21. Yuan J. P., Wang J. H., Liu X., Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Molecular Nutrition and Food Research 2007 51 7 765 781 2-s2.0-34547485050 10.1002/mnfr.200600262 (Pubitemid 47173687)
22. Setchell K. D. R., Brown N. M., Lydeking-Olsen E., The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 2002 132 12 3577 3584 2-s2.0-0036898114 (Pubitemid 35435031)
23. Mitchell J. H., Gardner P. T., McPhail D. B., Morrice P. C., Collins A. R., Duthie G. G., Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Archives of Biochemistry and Biophysics 1998 360 1 142 148 2-s2.0-0032421159 10.1006/abbi.1998.0951 (Pubitemid 29010923)
24. Rimbach G., De Pascual-Teresa S., Ewins B. A., Matsugo S., Uchida Y., Minihane A. M., Turner R., Vafeiadou K., Weinberg P. D., Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 2003 33 9 913 925 2-s2.0-0141884790 10.1080/0049825031000150444 (Pubitemid 37255402)
25. Hedlund T. E., Johannes W. U., Miller G. J., Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2003 54 1 68 78 2-s2.0-0037223129 10.1002/pros.10137 (Pubitemid 36043838)
26. Liew R., Williams J. K., Collins P., Macleod K. T., Soy-derived isoflavones exert opposing actions on guinea pig ventricular myocytes. Journal of Pharmacology and Experimental Therapeutics 2003 304 3 985 993 2-s2.0-0037371577 10.1124/jpet.102.042986 (Pubitemid 36254409)
27. Srivastava S., Verma M., Henson D. E., Biomarkers for early detection of colon cancer. Clinical Cancer Research 2001 7 5 1118 1126 2-s2.0-0034906359 (Pubitemid 32708660)
28. Tudek B., Bird R. P., Bruce W. R., Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Research 1989 49 5 1236 1240 2-s2.0-0024555694 (Pubitemid 19074843)
29. Corpet D. E., Pierre F., Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiology Biomarkers and Prevention 2003 12 5 391 400 2-s2.0-0038075469 (Pubitemid 36578475)
30. Matés J. M., Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000 153 1-3 83 104 2-s2.0-0034676493 10.1016/S0300-483X(00)00306-1
31. Sanders L. M., Henderson C. E., Hong M. Y., Barhoumi R., Burghardt R. C., Wang N., Spinka C. M., Carroll R. J., Turner N. D., Chapkin R. S., Lupton J. R., An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. Journal of Nutrition 2004 134 12 3233 3238 2-s2.0-10044256699 (Pubitemid 39602991)
32. Cotton S. C., Sharp L., Little J., Brockton N., Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. American Journal of Epidemiology 2000 151 1 7 32 2-s2.0-0033910990 (Pubitemid 30470391)
33. Habig W. H., Pabst M. J., Jakoby W. B., Glutathione S transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry 1974 249 22 7130 7139 2-s2.0-0016275313
34. Matés J. M., Pérez-Gómez C., Núñez de Castro I., Antioxidant enzymes and human diseases. Clinical Biochemistry 1999 32 8 595 603 2-s2.0-0037983267 10.1016/S0009-9120(99)00075-2 (Pubitemid 30039087)
35. Reeves P. G., Nielsen F. H., Fahey G. C., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition 1993 123 11 1939 1951 2-s2.0-0027487229 (Pubitemid 23342492)
36. Bird R. P., Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Letters 1987 37 2 147 151 2-s2.0-0023629080 (Pubitemid 17157833)
37. Sedlak J., Lindsay R. H., Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 1968 25 192 205 2-s2.0-0014428865
38. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441
39. Fridovich I., Superoxide dismutases. An adaptation to a paramagnetic gas. The Journal of Biological Chemistry 1989 264 14 7761 7764 2-s2.0-0024308039 (Pubitemid 19137245)
40. AACC, Approved Methods 1984 8th
41. Boateng J., Verghese M., Chawan C. B., Shackelford L., Walker L. T., Khatiwada J., Williams D. S., Red palm oil suppresses the formation of azoxymethane (AOM) induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food and Chemical Toxicology 2006 44 10 1667 1673 2-s2.0-33747058973 10.1016/j.fct.2006.05.002 (Pubitemid 44216076)
42. Dommels Y. E. M., Heemskerk S., van den Berg H., Alink G. M., van Bladeren P. J., van Ommen B., Effects of high fat fish oil and high fat corn oil diets on initiation of AOM-induced colonic aberrant crypt foci in male F344 rats. Food and Chemical Toxicology 2003 41 12 1739 1747 2-s2.0-0141922872 10.1016/S0278-6915(03)00201-1 (Pubitemid 37249341)
43. Bird R. P., Good C. K., The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters 2000 112-113 395 402 2-s2.0-0034653351 10.1016/S0378-4274(99)00261-1 (Pubitemid 30138150)
44. Dolara P., Caderni G., Luceri C., Surrogate endpoint biomarkers for human colon carcinogenesis. Toxicology Letters 2000 112-113 415 420 2-s2.0-17444443145 10.1016/S0378-4274(99)00215-5 (Pubitemid 30138153)
45. Stevens R. G., Swede H., Rosenberg D. W., Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Letters 2007 252 2 171 183 2-s2.0-34249287671 10.1016/j.canlet.2006.11.009 (Pubitemid 46809786)
46. Xiao H., Hao X., Simi B., Ju J., Jiang H., Reddy B. S., Yang C. S., Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 2008 29 1 113 119 2-s2.0-38849109982 10.1093/carcin/bgm204 (Pubitemid 351201749)
47. Reddy B. S., Rivenson A., El-Bayoumy K., Upadhyaya P., Pittman B., Rao C. V., Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. Journal of the National Cancer Institute 1997 89 7 506 512 2-s2.0-0030909726 (Pubitemid 27147267)
48. Toden S., Bird A. R., Topping D. L., Conlon M. A., Differential effects of dietary whey, casein and soya on colonic DNA damage and large bowel SCFA in rats fed diets low and high in resistant starch. British Journal of Nutrition 2007 97 3 535 543 2-s2.0-34047257837 10.1017/S0007114507336817 (Pubitemid 46662044)
49. Jacobsen H., Poulsen M., Dragsted L. O., Ravn-Haren G., Meyer O., Lindecrona R. H., Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutrition and Cancer 2006 55 2 163 170 2-s2.0-33750888316 10.1207/s15327914nc5502-7 (Pubitemid 44719630)
50. Verghese M., Rao D. R., Chawan C. B., Shackelford L., Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. Journal of Nutrition 2002 132 9 2804 2808 2-s2.0-0036716803 (Pubitemid 35013274)
51. Zduńczyk Z., Juśkiewicz J., Estrella I., Cecal parameters of rats fed diets containing grapefruit polyphenols and inulin as single supplements or in a combination. Nutrition 2006 22 9 898 904 2-s2.0-33747170602 10.1016/j.nut.2006.05.010 (Pubitemid 44234015)
52. Cummings J. H., Pomare E. W., Branch W. J., Naylor C. P. E., Macfarlane G. T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987 28 10 1221 1227 2-s2.0-0023276469 (Pubitemid 17156038)
53. Femia A. P., Luceri C., Dolara P., Giannini A., Biggeri A., Salvadori M., Clune Y., Collins K. J., Paglierani M., Caderni G., Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002 23 11 1953 1960 2-s2.0-0036849544 (Pubitemid 35355946)
54. Coxam V., Current data with inulin-type fructans and calcium, targeting bone health in adults. Journal of Nutrition 2007 137 11 2527S 2533S 2-s2.0-35848947202 (Pubitemid 350058730)
55. Boateng J., Verghese M., Shackelford L., Walker L. T., Khatiwada J., Ogutu S., Williams D. S., Jones J., Guyton M., Asiamah D., Henderson F., Grant L., DeBruce M., Johnson A., Washington S., Chawan C. B., Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food and Chemical Toxicology 2007 45 5 725 732 2-s2.0-33947425191 10.1016/j.fct.2006.10.019 (Pubitemid 46454425)
56. Wargovich M. J., Diallylsulfide and allylmethylsulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models. Journal of Nutrition 2006 136 3 832S 834S 2-s2.0-33644847036 (Pubitemid 43363787)
57. Ebert M. N., Klinder A., Peters W. H. M., Schäferhenrich A., Sendt W., Scheele J., Pool-Zobel B. L., Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 2003 24 10 1637 1644 2-s2.0-0142247518 10.1093/carcin/bgg122 (Pubitemid 37304668)
58. Pool-Zobel B. L., Selvaraju V., Sauer J., Kautenburger T., Kiefer J., Richter K. K., Soom M., Wölfl S., Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 2005 26 6 1064 1076 2-s2.0-22344443983 10.1093/carcin/bgi059 (Pubitemid 41214299)
59. Sauer J., Richter K. K., Pool-Zobel B. L., Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. British Journal of Nutrition 2007 97 5 928 937 2-s2.0-34147184817 10.1017/S0007114507666422 (Pubitemid 46554408)
60. Ohta A., Uehara M., Sakai K., Takasaki M., Adlercreutz H., Morohashi T., Ishimi Y., A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. Journal of Nutrition 2002 132 7 2048 2054 2-s2.0-0036303623 (Pubitemid 34742898)
61. Thiagarajan D. G., Bennink M. R., Bourquin L. D., Kavas F. A., Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. American Journal of Clinical Nutrition 1998 68 6 1394S 1399S 2-s2.0-0031741784 (Pubitemid 28550919)
62. Raju J., Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. World Journal of Gastroenterology 2008 14 43 6632 6635 2-s2.0-63449085306 10.3748/wjg.14.6632